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Abstract
Several methods have been proposed to impute genotypes at untyped markers using observed
genotypes and genetic data from a reference panel. We used the Genetic Analysis Workshop 16
rheumatoid arthritis case-control dataset to compare the performance of four of these imputation
methods: IMPUTE, MACH, PLINK, and fastPHASE. We compared the methods’ imputation error
rates and performance of association tests using the imputed data, in the context of imputing
completely untyped markers as well as imputing missing genotypes to combine two datasets
genotyped at different sets of markers. As expected, all methods performed better for single-
nucleotide polymorphisms (SNPs) in high linkage disequilibrium with genotyped SNPs. However,
MACH and IMPUTE generated lower imputation error rates than fastPHASE and PLINK.
Association tests based on allele “dosage” f r o mM A C Ha n dt e s t sb a s e do nt h ep o s t e r i o r
probabilities from IMPUTE provided results closest to those based on complete data. However, in
both situations, none of the imputation-based tests provide the same level of evidence of
association as the complete data at SNPs strongly associated with disease.
Background
Indirect association as a result of linkage disequilibrium
(LD) is a key factor in genetic association studies.
Because of LD, a disease-susceptibility single-nucleotide
polymorphism (SNP) need not be genotyped, as long as
it is tagged by a SNP or set of SNPs that are genotyped.
This concept has been further exploited by the introduc-
tion of methods to impute missing genotypes at untyped
markers, based on known genotypes at typed markers
and information about LD within the region from a
reference panel [1-4]. Such imputation methods can also
be applied in the context of combining data across
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in different studies.
Two recent studies compared imputation accuracy of
several methods [5,6]; however, these studies did not
assess performance of association tests based on the
imputed genotypes. In this paper, we compare the
performance of several imputation methods when
combining two datasets that have been genotyped at
different sets of markers or when completely missing
(i.e., “untyped”) markers are analyzed. Four commonly
used software packages were evaluated: IMPUTE [2],
MACH [4], PLINK [7], and fastPHASE [8]. Imputation
error rates and performance of association tests using the
imputed data were compared. The Genetic Analysis
Workshop (GAW) 16 Problem 1 dataset provided by the
North American Rheumatoid Arthritis Consortium
(NARAC) was used.
Methods
The NARAC data consisted of 868 cases of rheumatoid
arthritis (RA) and 1194 controls genotyped on the 550 k
Illumina SNP chip. Four regions were selected on
chromosome 1, each consisting of 30 consecutive
SNPs, representing regions with disease association
(PTPN22 [9,10] and PADI4 [11,12]) and without disease
association, and with high or low LD. SNPs deviating
from Hardy-Weinberg equilibrium (HWE) (p <0 . 0 0 1 )o r
with call rates below 95% were removed before analysis.
Two scenarios were considered: 1) imputation of
“untyped” markers and 2) imputation to combine two
datasets.
Scenario 1
A set of genotyped SNPs were removed completely and
subsequently imputed for all subjects. LD plots for the
regions as well as a list of removed SNPs are provided by
Fridley et al. in this volume [13]. For null regions 1 and
2, seven and eight SNPs were removed, respectively. For
the PTPN22 region, two datasets were created with four
SNPs excluded in addition to either the most strongly
associated SNP (rs2476601) or the two SNPs flanking
rs2476601. A similar approach was taken for the PADI4
region, with rs6683201 or the two SNPs flanking
rs6683201 removed in addition to five other SNPs.
Scenario 2
To represent the combined analysis of data from two
studies, cases and controls were randomly assigned to
two study populations, resulting in 434 cases and 597
controls per group. Genotypes at 10 randomly selected
SNPs from each region were removed for all individuals
in the first group. A second non-overlapping set of 10
random SNPs were deleted in the second group. Thus, in
each region, 10 SNPs were genotyped in both cohorts,
while 10 were genotyped only in cohort 1 and were
imputed in cohort 2, and 10 were genotyped in cohort 2
and imputed in cohort 1.
Imputation was performed using IMPUTE v 0.4.1 [2],
MACH v 1.0.16 [4], fastPHASE v 1.2.3 [8], and PLINK v
0.99 [7]. Haplotypes of the 60 HapMap CEU founders
were used as the reference data to run IMPUTE, MACH,
and PLINK for scenarios 1 and 2, and to run fastPHASE
for scenario 1. For fastPHASE, under scenario 2, only the
samples from the NARAC data were used. Programs were
run with default options, except to ensure convergence of
MACH, each dataset was run with 150 iterations
(“–rounds 150”option). In addition the option “–dose”
was used with MACH. For imputation of untyped SNPs
(scenario 1), the IMPUTE options “-exclude_SNPs file-
impute_excluded” were used, while for imputation
under scenario 2 the “-pgs” option was used. Full details
of the commands used may be obtained from the
authors by request.
Our assessment of error rates focused on the proportion
of incorrect genotypes obtained by imputing the most
likely genotype for each missing value, regardless of the
confidence in the imputation. Associations were assessed
assuming log-additive allelic effects on RA risk. p-Values
were calculated using the complete data and each set of
imputed data. In addition, for scenario 2, association
analyses using the “non-missing data” (genotypes avail-
able for only one group) were performed. Association
tests based on imputed data used “allele dose” from
MACH (the estimated number of minor alleles ranging
from 0 to 2), the most likely genotypes imputed using
fastPHASE and PLINK, and the posterior probabilities
from IMPUTE. For IMPUTE, association tests were
performed using the accompanying program SNPTEST,
with the “-proper-frequentist 1” options.
Results
Error rates
Overall, IMPUTE and MACH performed similarly and
outperformed PLINK and fastPHASE. Table 1 shows
error rates based on imputation of the most likely
genotype for each missing value overall, by region, and
by maximum pairwise LD. As expected, imputing
genotypes at SNPs that are in strong LD with genotyped
markers is much more likely to produce correct
genotypes. Figure 1 demonstrates this dependence of
error rates on LD, using results from scenario 2. Similar
results were obtained for scenario 1.
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Results of association tests based on imputed data are
summarized in Table 2 and Figures 2 and 3. Under
scenario 1, -log10(p-value) for association tests using
PLINK-imputed data showed the largest deviation from
the complete data -log10(p-value). However, with
respect to significance testing, the overall performance
of the four methods was similar. Performance of these
association tests was quite variable between SNPs, as
indicated by the large standard deviations in the
difference of the -log10(p-value).
Comparison of p-values from association tests based on
the original (complete) data with those that use the
imputed data reveals that for SNPs with small associa-
tion p-values, the imputed-data p-value tends to be larger
than the complete-data p-value, consistent with loss of
power. This is especially evident at SNP rs24776601 in
PTPN22, which is strongly associated with RA in the
c o m p l e t ed a t a .A tt h i sS N P ,M A C Ha n dI M P U T E
provided strongest evidence of association when it was
assumed that the SNP had not been genotyped at all
(Figure 2), while IMPUTE calculated to the smallest p-
value when it was assumed that the SNP had been
genotyped for half the subjects (Figure 3). In both
Table 1: Mean error rates by imputation method and scenario
IMPUTE MACH PLINK fastPHASE
Scenario 1: Imputation of untyped SNPs
Overall 0.112 0.114 0.142 0.135
By region
a null1 0.251 0.251 0.284 0.271
null2 0.066 0.066 0.090 0.085
PADI4-1 0.083 0.092 0.131 0.111
PADI4-2 0.106 0.109 0.144 0.162
PTPN22-1 0.099 0.098 0.122 0.107
PTPN22-2 0.061 0.059 0.069 0.058
By max pairwise r
2 < 0.5 0.208 0.212 0.245 0.248
LD r
2 ≥ 0.5 0.030 0.030 0.053 0.038
Scenario 2: Imputation to combine two datasets
Overall 0.116 0.112 0.173 0.127
By region
a null1 0.206 0.201 0.250 0.218
null2 0.123 0.122 0.175 0.139
PADI4 0.079 0.069 0.145 0.097
PTPN22 0.055 0.053 0.121 0.053
By max pairwise r
2 < 0.5 0.200 0.197 0.256 0.211
LD r
2 ≥ 0.5 0.046 0.041 0.105 0.059
aIn Scenario 1, for regions PADI4-1 and PTPN22-1, the most strongly associated SNP was removed and imputed, while for regions PADI4-2 and
PTPN22-2, the two SNPs flanking the most strongly associated SNP were imputed, in addition to other SNPs as described in the methods.
0.0 0.2 0.4 0.6 0.8 1.0
0
.
0
0
.
1
0
.
2
0
.
3
0
.
4
0
.
5
0
.
6
maximum pairwise r
2
S
N
P
 
m
e
a
n
 
i
m
p
u
t
a
t
i
o
n
 
e
r
r
o
r
 
r
a
t
e
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l l
l
l
l l
l l
l
l
l l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l l
l
l
l
l
l
l
l IMPUTE
MACH
plink
fastPH
Figure 1
Imputation error rates decline with increasing LD
(scenario 2).
Table 2: Mean (SD) difference
a in -log10(p-value) based on a test
of association using complete data and a test of association using
the imputed data
Scenario 1 Scenario 2
IMPUTE 0.352 (1.26) 0.078 (0.493)
MACH 0.363 (1.27) 0.093 (0.543)
PLINK 0.509 (1.55) 0.054 (0.617)
fastPHASE 0.483 (1.70) 0.046 (0.633)
aDifference = (imputed data -log10(p-value)) - (complete data -log10(p-
value)).
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tially less evidence of association than the complete data.
Discussion
We compared the performance of four commonly used
packages for imputation of missing genotype data as well
as subsequent tests of association. A key disadvantage of
fastPHASE is that it only provides the most likely
genotype, while MACH provides an estimate of allele
dose, and IMPUTE and PLINK provide estimates of
posterior probabilities of all possible genotypes. In
agreement with published studies [5,6], when imputing
the most likely genotype for each missing value, using
MACH and IMPUTE generated lower overall error rates
than the other approaches. As expected, imputation was
more accurate for SNPs in higher LD with genotyped
SNPs. Our method of calculating the error rate did not
take into account whether one or two of the alleles are
incorrectly imputed. A measure of imputation accuracy
that reflects the number of correctly imputed alleles, or
uses the posterior probabilities of possible genotypes,
could be considered.
On average, association tests based on imputed data gave
similar results to the test based on the complete
(“unknown”) data. However, at the strongest association
peak, the imputation-based tests were much less
significant than the complete-data test, indicating that
using imputation methods followed by association
testing can severely underestimate significance at asso-
ciation peaks. This finding may be partially due to the
fact that the reference haplotypes used for imputation
are representative of a population-based sample that is
comparable to the control sample. Dense genotyping of
a subset of cases and controls from a given study and use
of the resulting haplotypes as the reference data may
improve the power of association tests based on imputed
data. Further investigation of such an approach is
warranted. Although imputation-based tests can under-
estimate the significance at strongly associated SNPs,
they can also lead to results more significant than tests
for nearby markers that were genotyped and are
indirectly associated with the trait. As with any imputa-
tion-based analysis, such results should be interpreted
cautiously and the region should be further investigated.
Conclusion
All methods performed well for SNPs in high LD with
genotyped SNPs. However, MACH and IMPUTE gener-
ated lower overall imputation error rates and more
reliable association test results than fastPHASE and
PLINK. Further investigation of the relative merits of
using allele doses or posterior genotype probabilities is
warranted. The fact that imputation-based tests can
02468 1 0 1 2
0
2
4
6
8
1
0
1
2
−log10 complete−data p−value
−
l
o
g
1
0
 
i
m
p
u
t
e
d
 
d
a
t
a
 
p
−
v
a
l
u
e
l l l
l
l
l
l
l
l l l
l l l
l l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l
l
l
l
l
l
l
l
l IMPUTE
MACH
PLINK
fastPHASE
Figure 2
Comparison of association test results (-log10(p-
value)) based on complete data with tests based on
imputed data under scenario 1 (imputation of
untyped markers).
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Figure 3
Association test results (-log10(p-value)) based on
different imputation methods in the PTPN22 region
under scenario 2 (imputation to combine two
datasets).
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peaks warrants caution in using these methods to
exclude SNPs from further follow-up.
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